Parexel International (ma) Corporation
Location
Massachusetts
Founded
1983-02-28
Website
Risk Signals
451 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Commercial Physical and Biological Research), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Parexel International (ma) Corporation
Live alerts from global media, monitored by Business Radar

2024-09-24 (biotecnika.org)
Remote Life Sciences Jobs at Parexel – Apply For Program Coordinator Role
Remote Life Sciences Job at Parexel - Apply For Program Coordinator Role. Life Sciences Jobs at Parexel. Parexel Remote Jobs.
Read more
2024-09-06 (biotecnika.org)
Parexel Biological Sciences Clinical Operations Assistant Role – Apply Online
Parexel Biological Sciences Clinical Operations Assistant Role - Apply Online. Biological Sciences Jobs. Parexel Biological Sciences Vacancy
Read more2024-02-13 (pharmatutor.org)
PAREXEL looking for Senior Regulatory Affairs Associate
PAREXEL has supported the Bio-Tech and Pharmaceutical industries in helping the development of new drugs and treatments on a global basis. As a leading global biopharmaceutical service provider, they supply knowledge-based contract research, medical communications and consulting services across a
Read more
2023-12-13 (ottawasun.com)
ACRO Announces 2024 Officers and New Members
WASHINGTON — ACRO today announced that its Board of Directors has elected Peyton Howell, Chief Operating & Growth Officer at Parexel, as Chair of the...
Read more2023-11-10 (xtalks.com)
Easing the Challenges of Global Feasibility: Strategies to Balance Priorities, Manage Disparate Data Sources and Mitigate Risk
Explore the challenges of global feasibility and gain insights into strategies for successful study start-ups, like protocol optimization, geostrategy and site selection.
Read more2023-09-19 (globenewswire.com)
Parexel Appoints Gwyn Bebb, BM, BCh., Ph.D., to Lead Oncology Clinical Development
Appointment further strengthens company’s expertise in fastest-growing therapeutic area to meet patient need...
Read more2023-09-19 (yahoo.com)
Parexel Appoints Gwyn Bebb, BM, BCh., Ph.D., to Lead Oncology Clinical Development
Appointment further strengthens company’ s expertise in fastest-growing therapeutic area to meet patient need Parexel Gwyn Bebb, BM, BCh., Ph.D., Senior Vice President and Global Therapeutic Area Head -- Oncology DURHAM, N.C., Sept. 19, 2023( GLOBE NEWSWIRE) -- Parexel, one of the world’ s largest
Read more2022-09-14 (globenewswire.com)
Parexel Appoints Peyton Howell Chief Operating and Growth
Key leadership appointments focused on enhancing connections and collaboration to drive Innovation across the next-generation delivery of clinical trials...
Read more2022-06-14 (prnewswire.com)
Riverside Partners' Portfolio Company, Syner-G BioPharma Group, Appoints Ron Kraus as CEO
/PRNewswire/ -- Riverside Partners, a Boston based private equity firm, announced today that its portfolio company, Syner-G BioPharma Group ("Syner-G" or the...
Read more